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Elevated Intra-Abdominal Pressure
in Acute Decompensated Heart Failure
A Potential Contributor to Worsening Renal Function?
Wilfried Mullens, MD,* Zuheir Abrahams, MD, PHD,* Hadi N. Skouri, MD,*
Gary S. Francis, MD, FACC,* David O. Taylor, MD, FACC,*
Randall C. Starling, MD, MPH, FACC,* Emil Paganini, MD,† W. H. Wilson Tang, MD, FACC*
Cleveland, Ohio
Objectives This study sought to determine whether changes in intra-abdominal pressure (IAP) with aggressive diuretic or
vasodilator therapy are associated with improvement in renal function in acute decompensated heart failure
(ADHF).
Background Elevated IAP (8 mm Hg) is associated with intra-abdominal organ dysfunction. There is potential for ascites
and visceral edema causing elevated IAP in patients with ADHF.
Methods Forty consecutive patients admitted to a specialized heart failure intensive care unit for management of ADHF
with intensive medical therapy were studied. The IAP was measured using a simple transvesical technique at
time of admission and before removal of the pulmonary artery catheter.
Results In our study cohort (mean age 59  13 years, mean left ventricular ejection fraction 19  9%, baseline serum
creatinine 2.0  0.9 mg/dl), the mean baseline IAP was 8  4 mm Hg, with 24 (60%) patients having elevated
IAP. Elevated IAP was associated with worse renal function (p  0.009). Intensive medical therapy resulted in
improvement in both hemodynamic measurements and IAP. A strong correlation (r  0.77, p  0.001) was ob-
served between reduction in IAP and improved renal function in patients with baseline elevated IAP. However,
changes in IAP or renal function did not correlate with changes in any hemodynamic variable.
Conclusions Elevated IAP is prevalent in patients with ADHF and is associated with impaired renal function. In the setting of
intensive medical therapy for ADHF, changes in IAP were better correlated with changes in renal function than
any hemodynamic variable. (J Am Coll Cardiol 2008;51:300–6) © 2008 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.09.043w
i
c
t
i
t
A
s
H
a
H
I
a
t
i
aespite recent medical advances, the pathophysiology of
cute decompensated heart failure (ADHF) remains poorly
nderstood, particularly regarding the cardiorenal interac-
ions. In many cases of heart failure, coexisting renal
ysfunction may complicate the treatment course. In addi-
ion, therapies that alleviate congestion, such as loop diuret-
cs, which remain a mainstay of the therapeutic armament
gainst heart failure, can worsen renal insufficiency and may
ven increase mortality (1,2).
There has been increasing interest in measuring intra-
bdominal pressure (IAP) in critically ill patients because
levated IAP has been associated with intra-abdominal
rgan dysfunction (3,4). The compliance of the abdominal
rom the Sections of *Heart Failure and Cardiac Transplantation and †Nephrology
nd Hypertension, the Cleveland Clinic, Cleveland, Ohio.A
Manuscript received July 9, 2007; revised manuscript received August 31, 2007,
ccepted September 7, 2007.all generally limits the increases in IAP as abdominal girth
ncreases. However, once a critical volume is reached,
ompliance of the abdominal wall decreases abruptly. Fur-
her distention beyond this critical IAP results in a rapid
ncrease in abdominal pressure and resultant organ dysfunc-
ion (5,6). Recently, during the second World Congress on
bdominal Compartment Syndrome, medical critical care
pecialists defined a normal IAP to be between 5 and 7 mm
g in critically ill adults, an elevated IAP to be8 mm Hg,
nd intra-abdominal hypertension (IAH) to be 12 mm
g (7).
It has been recognized over the past century that elevated
AP can directly lead to renal compromise in the setting of
bdominal compartment syndrome or other surgical condi-
ions involving visceral edema (4–6). However, data regard-
ng measurements of IAP in patients admitted with ADHF
re lacking despite the potential for a substantial part of
DHF patients to present with ascites, visceral edema, and
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January 22, 2008:300–6 Elevated Intra-Abdominal Pressure in Heart Failurempaired renal function. The primary goal of our study was
o test the hypothesis that IAP is commonly elevated in
atients admitted with ADHF. The secondary goal was to
nvestigate whether intensive medical therapy can reduce
AP and whether reduction in IAP may lead to correspond-
ng improvement in renal function.
ethods
atient population. We prospectively enrolled consecutive
atients ages 18 years or older with symptomatic heart
ailure (New York Heart Association functional class III to
V) who underwent a right heart catheterization and were
dmitted to the Cleveland Clinic heart failure intensive care
nit for intensive medical therapy between November 1,
006, and May 31, 2007. Subjects who met the following
nclusion criteria were enrolled into the study: 1) markedly
mpaired systolic left ventricular function defined by left
entricular ejection fraction 30%, and 2) elevated filling
ressures, as defined by pulmonary capillary wedge pressure
PCWP)18 mm Hg and right atrial pressure8 mm Hg.
xclusion criteria included: 1) patients on artificial ventila-
ion; 2) patients who had undergone abdominal or thoracic
urgery within the last 3 months; 3) patients without a Foley
atheter; and 4) patients on renal replacement therapy. The
leveland Clinic Institutional Review Board approved this
roject. Informed consent was obtained as part of the
reatment and all invasive procedures during hospitalization,
nd was documented in the patient charts according to
rotocol and Cleveland Clinic policy.
rug titration protocols. The hemodynamic goals and
harmacologic approach to intravenous therapy in the
pecialized heart failure intensive care unit have been
reviously described (8). Briefly, optimal hemodynamic
esponse was defined as a decrease in PCWP to 18 mm
g, decrease in central venous pressure (CVP) to 8 mm
g, and improvement in cardiac index (CI) to 2.2
/min/m2, all while maintaining mean arterial pressure (MAP)
65 mm Hg. To achieve the hemodynamic goals, most
atients were treated according to standard protocols devel-
ped in our intensive care unit with intravenous loop diuretics
n combination with vasodilators (i.e., nitroprusside) and/or
notropic agents while continuing previous therapies with
ngiotensin-converting enzyme inhibitors, beta-blockers, and
pironolactone as tolerated. Loop diuretics were given as a
ontinuous infusion with or without an initial bolus at the
iscretion of the attending physician.
AP measurement. Clinical examination of the abdomen
nd/or the abdominal perimeter is not an accurate indicator
f IAP (9,10). To obtain a precise IAP value, the pressure
s measured with the transvesical method (11,12). Briefly,
AP is measured via a standard Foley catheter, which is
onnected with a pressure transducer placed in-line with the
liac crest at the midaxillary line (Fig. 1). The Foley catheter
s flushed with a maximal instillation volume of 50-ml
terile saline via the aspiration port of the Foley catheterith the drainage tube clamped
o allow a fluid-filled column to
evelop up into the bladder. In-
tallation of more volume can
ead to bladder distention, which
an be uncomfortable to the pa-
ient and lead to increased intra-
esical pressure. This could thus
ive rise to a falsely high IAP
easurement. A pressure trans-
ucer is then inserted in the as-
iration port, and the pressure is
easured. The IAP is expressed
n mm Hg and is measured at
nd-expiration in the supine po-
ition, ensuring that abdominal
uscle contractions are absent.
n this study, the IAP is mea-
ured on admission before drug
nitiation and before removal of
he pulmonary artery catheter
36  12 h later). The interob-
erver and intraobserver variabilities of IAP measurements
ere compared in 30 consecutive IAP measurements, and
ere found to be 5% and 4%, respectively.
ata collection and variable definitions. Data were col-
ected by 3 experienced heart failure cardiologists. The
ollowing additional data were recorded: demographic char-
cteristics, medical history, medical treatment, implanted
acemaker and implantable cardioverter defibrillator device
nformation, and echocardiographic data. In all patients,
Abbreviations
and Acronyms
ADHF  acute
decompensated heart
failure
CI  cardiac index by Fick
equation
CVP  central venous
pressure
FG  renal filtration
gradient
GFR  glomerular filtration
rate
IAH  intra-abdominal
hypertension
IAP  intra-abdominal
pressure
MAP  mean arterial
pressure
PCWP  pulmonary
capillary wedge pressure
Figure 1 Transvesical Method for
Measuring Intra-Abdominal Pressure
Bedside technique using conventional Foley catheter
filled with saline and connected to a hemodynamic monitor.
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Elevated Intra-Abdominal Pressure in Heart Failure January 22, 2008:300–6erum creatinine levels on admission and before removal of
he pulmonary artery catheter were recorded. Estimated
lomerular filtration rate (GFR) was calculated using the
bbreviated Modification of Diet in Renal Disease study
ormula: GFR for men  186  (serum creatinine
mol/l]  0.0113)  1.154  age (years)  0.203. For
omen the result was multiplied by 0.742 and for African
mericans by 1.210.
emodynamic assessment. Complete hemodynamic as-
essment was performed in all patients before the start of
ntensive medical therapy, and again before removing the
ulmonary artery catheter. The CVP and PCWP were
ssessed at end-expiration with a balloon-tipped catheter at
teady state with the patient in a supine position. The CI
as determined by calculation using the Fick equation
hrough sampling of a mixed central venous blood gas
easurement taken in the pulmonary artery while assuming
tandard metabolic rates. The MAP was calculated as
systolic blood pressure  2  diastolic blood pressure)/3.
he abdominal perfusion pressure was determined by fol-
owing equation: MAP  IAP (12). The renal filtration
radient (FG) is the mechanical force across the glomeruli
nd can be estimated as: glomerular filtration pressure
inus proximal tubular pressure (12). In the presence of
levated IAP, proximal tubular pressure may be assumed to
qual IAP, and thus glomerular filtration pressure can be
stimated as: MAP  IAP. The FG was therefore calcu-
ated as: MAP  2  IAP.
tatistical analysis. All data are expressed as mean  SD
or continuous data and as percent ratio for categorical data.
nivariate comparisons of these variables were performed
etween baseline and follow-up variables and between
atients with normal versus elevated IAP (8 mm Hg)
sing SPSS for Windows, release 11.5 (SPSS Inc., Chicago,
llinois). A paired and unpaired t test for continuous data
nd Pearson correlation coefficients were used for appropri-
te comparisons. Statistical significance was set at a two-
ailed probability level of 0.05.
esults
aseline characteristics and medical treatment. A total
f 40 patients met eligibility criteria and were enrolled in the
tudy. Baseline characteristics and treatment during admis-
ion of the patients stratified according to IAP 8 mm Hg
n  24) and IAP 8 mm Hg (n  16) are summarized in
able 1. All patients were classified as New York Heart
ssociation functional class III or IV. Mean left ventricular
jection fraction was similar between the 2 patient groups,
s was the percentage of patients with moderate to severe
ight ventricular systolic dysfunction (38% in both groups).
here were no statistically significant differences in medical
herapy on admission or during intensive medical therapy
etween the 2 patient groups.
No patient complained of abdominal discomfort ondmission or during treatment. The median length of areatment (from baseline to follow-up, defined as change in
ll measurements) was 36  10 h and 36  14 h in the
atients with normal IAP and elevated IAP, respectively
p  0.9).
APmeasurements. In the overall cohort, the mean IAP at
aseline was 8  4 mm Hg, which improved to a mean of
 3 mm Hg after medical therapy (p 0.001). The mean
AP in the cohort of patients with elevated IAP (n 24) on
dmission was 10  2 mm Hg, which was also significantly
educed at follow-up to 6  3 mm Hg (p  0.001) (Fig. 2).
our (10%) patients presented with IAH on admission, and
hey too had a significant decrease in IAP at follow-up
15  3 mm Hg to 7  2 mm Hg, p  0.001). Only 3
atients who presented with elevated IAP had an increase of
AP at follow-up. No urinary tract infection or abdominal
iscomfort was seen in any patient during the treatment
eriod.
emodynamic and renal variables at baseline and follow-
p. Table 2 illustrates the hemodynamic measurements on
dmission and after intensive medical therapy in all patients,
aseline Patient Characteristicsccording to IAP >8 mm Hg and IAP <8 mm Hg
Table 1 Baseline Patient CharacteristicsAccording to IAP >8 mm Hg and IAP <8 mm Hg
Patients With IAP
>8 mm Hg
(n  24)
Patients With IAP
<8 mm Hg
(n  16) p Value
Demographics and
vital statistics
Mean age (yrs) 58 11 61 14 NS
Men (%) 67 62 NS
Weight (kg) 94 23 82 17 NS
Height (cm) 177 10 172 7 NS
Hypertension (%) 70 47 0.04
Hyperlipidemia (%) 46 53 NS
Diabetes (%) 37 34 NS
Smoking (%) 30 20 0.05
Previous CABG (%) 35 33 NS
ICD/CRT-D (%) 63 60 NS
Idiopathic dilated (%) 62 68 NS
Ischemic (%) 38 32 NS
Ejection fraction (%) 19 8 21 12 NS
Hemoglobin (g/dl) 11 2 11 2 NS
Medication on
admission (%)
Beta-blockers 62 56 NS
ACE inhibitors/ARB 62 62 NS
Spironolactone 46 44 NS
Loop diuretic 96 100 NS
Parenteral medication
during admission (%)
Loop diuretics 82 86 NS
Nitroprusside 45 46 NS
Dobutamine 24 26 NS
Milrinone 31 27 NS
alues are mean  standard deviation or n (%).
ACE  angiotensin-converting enzyme; ARB  angiotensin receptor blocker; CABG  coronary
rtery bypass graft; CRT-D  cardiac resynchronization therapy with defibrillator; ICD  implant-
ble cardioverter-defibrillator.s well as for the subgroup of patients with elevated IAP and
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January 22, 2008:300–6 Elevated Intra-Abdominal Pressure in Heart Failureormal IAP. Overall MAP, CI, PCWP, CVP, and abdom-
nal perfusion pressure were comparable between the 2
ohorts at baseline and at follow-up. All patients had signs
f impaired hemodynamics with elevated right-sided and
eft-sided filling pressures, which significantly improved
fter parenteral administration of vasodilators, diuretics,
nd/or inotropic therapy.
Patients with elevated baseline IAP or IAH had higher
erum creatinine levels at baseline (2.3  1.0 mg/dl vs.
.5  0.8 mg/dl, p  0.009) and at follow-up (1.8  0.8
g/dl vs. 1.3  0.9 mg/dl, p  0.04) compared with those
ho had a normal IAP at baseline. As shown in Figure 3,
AP was related to impaired renal function. The renal
ltration gradient was statistically lower at baseline in the
atients with elevated IAP versus those with normal IAP
56  14 mm Hg vs. 65  10 mm Hg, p  0.03).
urthermore, in those with elevated IAP at baseline, there
as an average increase of renal filtration gradient from
6  14 mm Hg to 64  12 mm Hg (p  0.01) that
aralleled with an improvement in mean GFR (40  21
l/min to 49  23 ml/min, p  0.003) as well as in serum
reatinine (2.3  1.0 mg/dl to 1.8  0.8 mg/dl, p  0.01).
Figure 2 Change in IAP in Patients With
Baseline Elevated Intra-Abdominal Pressure
Noted overall trend of reduction in intra-abdominal
pressures (IAP) in patients with IAP at 8 mm Hg at baseline.
emodynamic Variables on Admission and Time of Pulmonary Arterval in All Patients a d Stratified According to IAP >8 mm Hg
Table 2 Hemodynamic Variables on Admission and Time of PulRemoval in All Patients and Stratified According to IAP
All Patients (n  40) Pati
Baseline Follow-Up p Value Base
MAP (mm Hg) 75 13 73 11 NS 78
CVP (mm Hg) 15 7 11 6 0.001 16
PCWP (mm Hg) 22 6 17 4 0.001 22
CI (l/min/m2) 2.1 0.9 2.6 0.7 0.001 2.1
IAP (mm Hg) 8 4 5 3 0.001 10
APP (mm Hg) 68 12 69 11 NS 68
FG (mm Hg) 61 13 64 11 NS 56
Creatinine (mg/dl) 2.0 0.9 1.6 0.9 0.002 2.3
GFR (ml/min) 50 35 61 44 0.001 40PP abdominal perfusion pressure; CI cardiac index; CVP central venous pressure; FG renal filtrat
apillary wedge pressure.elation between changes in IAP, hemodynamic vari-
bles, and renal function. Table 3 illustrates the relation-
hip between changes in hemodynamic variables and renal
unction changes in all patients and in those with elevated
AP. Although there was a significant reduction in right-
ided and left-sided filling pressures together with an
mproved cardiac index, these hemodynamic improvements
id not correlate with improvements in renal function or
AP. Changes in IAP (either an increase or a decrease) after
ntensive medical therapy correlated with changes in renal
unction (r  0.77, p  0.001), and this only in patients
ith elevated IAP (Fig. 4A). Patients who had an increase
n IAP at follow-up also had a deterioration of their renal
theterIAP <8 mm Hg
ry Artery Catheter
mm Hg and IAP <8 mm Hg
ith IAP >8 mm Hg (n  24) Patients With IAP <8 mm Hg (n  16)
Follow-Up p Value Baseline Follow-Up p Value
75 11 NS 72 11 72 11 NS
13 7 0.001 13 6 9 5 0.05
17 3 0.001 23 8 18 5 0.03
2.7 0.7 0.001 2.2 1.0 2.5 0.6 0.05
6 3 0.001 3 1 3 1 NS
69 11 NS 68 11 69 11 NS
64 12 0.01 65 10 66 11 NS
1.8 0.8 0.01 1.5 0.8 1.3 0.9 NS
49 23 0.003 63 46 77 58 NS
Figure 3 Baseline Serum Creatinine Level and IAP
Box and whisker plot with median, quartiles, and extremes for serum creatinine
levels for all patients with intra-abdominal pressure (IAP) 8 mm Hg and 8
mm Hg at baseline. Note that there is a statistically higher serum creatinine
level in patients with a higher IAP.y Caand
mona
>8
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7
5
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21ion gradient; IAP intra-abdominal pressure; MAPmean arterial pressure; PCWP pulmonary
f
n
3
r
h
b
c
s
c
D
T
s
w
t
I
i
a
w
s
i
O
I
c
m
i
p
n
l
(
u
d
e
b
(
s
t
t
t
t
o
w
m
A
w
e
t
A
p
a
w
ne; othe
304 Mullens et al. JACC Vol. 51, No. 3, 2008
Elevated Intra-Abdominal Pressure in Heart Failure January 22, 2008:300–6unction. The 1 patient who initially presented with a
ormal IAP and had an increase of IAP at follow-up (from
to 8 mm Hg) also showed a corresponding worsening of
enal function from baseline to follow up. No differences in
emodynamic profile or therapeutic regimen were noticed
etween patients in whom IAP increased during treatment
ompared with those in whom it did not. There was a
ignificant negative correlation between changes in FG and
hanges in creatinine (r  0.65, p  0.001) (Fig. 4B).
Relation of Changes in IAP or Serum CreatinineVariables Stratified According to All Patients an
Table 3 Relation of Changes in IAP or SerumVariables Stratified According to Al
All Patients (n 
Changes in IAP C
r p Value
Changes in MAP (mm Hg) 0.17 NS 0
Changes in CVP (mm Hg) 0.05 NS 0
Changes in PCWP (mm Hg) 0.01 NS 0
Changes in CI (l/min/m2) 0.01 NS 0
NS  nonsignificant; r  correlation coefficient; sCr  serum creatini
Figure 4 Changes in Renal Parameters and Changes in IAP
Relationship between changes in renal function and changes in intra-abdominal
pressure (IAP) (A) and estimated renal filtration gradient (B) in patients with
IAP 8 mm Hg at baseline.tiscussion
here are several key findings in this hypothesis-generating
tudy. First, patients with advanced heart failure presenting
ith ADHF have a high prevalence of elevated IAP despite
he absence of overt abdominal symptoms. Second, elevated
AP is associated with more impaired renal function. Third,
mprovement in renal function after medical therapy is
ssociated with a reduction of IAP, yet bears no relationship
ith changes in hemodynamic measurements. Fourth, mea-
urement of IAP is simple, safe, inexpensive, and reproduc-
ble with equipment readily available in the clinical setting.
ur clinical observations raise the possibility that increased
AP might contribute, in part, to the renal dysfunction
ommonly observed in patients with ADHF. Although the
echanism is unclear, both reduced renal perfusion and
ncreased renal vein pressure (and thus increased renal
ressure) might be a consequence of increased IAP.
Elevated IAP among critically ill patients has predomi-
antly been described in the surgical and critical care
iterature in scenarios involving abdominal catastrophes
3,4,13). As the pathophysiology of IAP becomes better
nderstood, the importance of IAP measurements in the
iagnosis and management of elevated IAP and IAH has
volved. The abdomen can be considered a closed box with
oth rigid (costal arch, spine, and pelvis) and flexible
abdominal wall and diaphragm) walls, thus the IAP mea-
ured at one point may be assumed to represent the IAP
hroughout the abdomen (14,15). However, it is important
o remember that clinical judgment and physical examina-
ion are far from accurate in estimating IAP (9,16). The
ransvesical IAP pressure measurement depends on the wall
f the bladder functioning as a transducing membrane
ithout imparting any additional pressure from its own
usculature, allowing it to act as a passive reservoir (17,18).
lthough a substantial number of ADHF patients present
ith ascites and visceral edema, both potential causes of
levated IAP, no reports in the literature have studied
he prevalence and potential role of elevated IAP in
DHF patients. As shown by our study, elevated IAP in
atients presenting with ADHF is common (60%), with
smaller proportion (10%) demonstrating IAH, which
as not detected on routine history and physical examina-
HemodynamicPatients With IAP >8 mm Hg
atinine With Hemodynamic
ents and in Patients With IAP >8 mm Hg
Patients With IAP >8 mm Hg (n  24)
s in sCr Changes in IAP Changes in sCr
p Value r p Value r p Value
NS 0.02 NS 0.37 NS
NS 0.16 NS 0.09 NS
NS 0.01 NS 0.l7 NS
NS 0.03 NS 0.11 NS
r abbreviations as in Table 2.Withd in
Cre
l Pati
40)
hange
r
.26
.23
.23
.08ion. None of the patients in this study presented with
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January 22, 2008:300–6 Elevated Intra-Abdominal Pressure in Heart Failurebdominal discomfort as a subjective sign of elevated IAP,
hich shows that this phenomenon is often, if not always,
symptomatic in ADHF patients. One explanation might
e that the fluid build-up in these patients is often gradual
ver weeks, and thus the increase in IAP may also be slow
nd insidious. Lowering of the IAP was likely caused by
obilization of fluid from the third space through a
ombination of aggressive diuretic, vasodilator, and/or ino-
ropic therapy. Successful intensive medical therapy, as
videnced by a reduction in right-sided and left-sided filling
ressures together with improved cardiac output, coincided
ith the observed reduction in IAP in most patients.
owever, no correlation between changes in any hemody-
amic variable or alterations in IAP was observed. This
otentially explains why patients with improved hemody-
amics may subsequently develop worsening renal function
fter aggressive therapy during ADHF admission if there is
ersistent elevation of IAP. Our data corroborate this
ypothesis because all patients whose renal function dete-
iorated during treatment had an increase in IAP at follow-
p, however, with improved hemodynamics.
An inadequate renal filtration gradient has been identi-
ed as a key factor in the development of renal dysfunction
19,20). Patients with an acute exacerbation of advanced
eart failure often present with a low systemic blood
ressure and impaired cardiac index (21). Both factors may
ubstantially reduce renal blood flow, the most important
ariable of the FG in patients presenting with congestive
eart failure (22,23). Consequently, even small elevations in
AP lead to significant reductions in FG. Indeed, a statis-
ically significant reduction of the FG was noticed in the
atients who presented with elevated IAP compared with
he patients with normal IAP, although both groups had a
omparable reduction in cardiac index and mean systemic
rterial blood pressure. Moreover, changes in FG were
losely correlated with changes in renal function, thereby
mphasizing the importance of an adequate FG. Impaired
ardiac index and increased filling pressures seen in ad-
anced heart failure patients with ADHF will further
ctivate the renin-angiotensin and sympathetic nervous
ystem, reduce nitric oxide in the endothelium, and induce
nflammatory mediators, thus aggravating the hypoperfu-
ion state of the glomeruli (24).
Elevated IAP may also lead to renal vein and ureter
ompression, further impairing renal function (4,25,26).
lthough impairment of venous return probably plays a role
27), it cannot by itself completely explain the manifesta-
ions of renal function improvement after normalizing the
AP, because the reduction of right- and left-sided filling
ressures was not correlated with improved renal function.
nstead, elevated IAP is transdiaphragmatically transmitted
nd may give rise to elevation of intrathoracic pressures
4,6). This may result in elevated pulmonary pressure, CVP,
nd capillary wedge pressure readings from the pulmonary
rtery catheter. In addition, increased IAP decreases venous
eturn by obstructing the inferior vena cava blood flow in fhe abdomen, decreasing cardiac output, and increasing the
isk for peripheral edema and venous thrombosis (28–30).
s a result, elevated IAP in ADHF patients makes preload
ssessment difficult and further compromises the already-
mpaired left ventricle. Furthermore, measured intravascular
ressures are not reflective of intravascular volumes, and
nappropriate diuretic admission might increase the risk of
enal function worsening.
It is important to emphasize that although the degree of
enal dysfunction was correlated with the degree of elevated
AP, there was a wide range of IAPs in relation to serum
reatinine levels on presentation. Our findings regarding the
elationship between changes in IAP and changes in renal
unction are primarily focused on those with elevated IAP at
aseline. These findings corroborate the hypothesis that the
esponse of IAP to treatment rather than the absolute level
f IAP on admission is contributing to improved or wors-
ning renal function.
tudy limitations. There are several limitations in our
bservational series, including the relatively small sample
ize, the lack of any outcomes data on renal function after
ospital discharge, the lack of any urinalysis, the adoption of
he technique of IAP measurement used in the surgical
iterature, and the lack of physiological measurements (such
s direct assessment of intraparenchymal renal pressures and
enal blood flow) to fully explain the complex underlying
athophysiology. However, our observations are unique,
ecause the prevalence of increased IAP in patients without
bvious abdominal symptoms in ADHF has not been
reviously reported. Animal data have suggested that in-
reased intraparenchymal pressure may not contribute to
enal dysfunction (5). Although clinically not apparent, we
id not routinely perform an abdominal ultrasound to
onfirm ascites as a contributing factor to the elevated IAP.
dditionally, serial measurements of abdominal girth as a
otential indicator of reduction in IAP during therapy were
ot performed. Further studies are necessary to better
nderstand the exact pathophysiology underlying this car-
ioabdominal interaction and whether there is a cause-and-
ffect relationship between IAP and worsening renal func-
ion. The extent to which elevated IAP contributes to the
bserved renal dysfunction in our ADHF population re-
uires further investigation.
onclusions
n patients admitted with advanced decompensated heart
ailure, we observed a high prevalence of elevated intra-
bdominal pressure, which is associated with impaired renal
unction. A strong correlation between reduction in IAP
nd improvement in renal function was observed, although
t was independent of hemodynamic changes. Measurement
f IAP in patients with ADHF should be considered to
ssist in the management of these patients because changes
n IAP with therapy are predictive of changes in renal
unction.
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